Generative AI for the Revenue Cycle
AKASA (akasa.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, SaaS brands, Technology brands, in the 80th percentile of 9593 Healthcare brands.
AKASA is a healthcare technology company that provides generative AI (GenAI) solutions for revenue cycle management, covering prior authorization, clinical documentation improvement (CDI), coding, and claims management. It combines revenue cycle management expertise with AI trained on clinical and financial data to help health systems and hospitals reduce denials, lower costs, and improve revenue outcomes. AKASA targets health systems, hospitals, and other healthcare organizations seeking to modernize revenue cycle operations through automation and AI-driven tools.
| Brand Name | AKASA |
|---|---|
| Domain | akasa.com |
| Industry | Healthcare, SaaS |
| Founded | 1995 |
| Main Competitors | Waystar (86/100), R1 RCM (60/100), Olive AI (81/100), Notable Health (82/100), XSOLIS (76/100), Cotiviti (76/100), Optum (94/100), Nuance (Microsoft) (86/100) |
Moz Domain Authority 42/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,025,104 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
AKASA appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "AKASA provides generative AI (GenAI) solutions for the healthcare revenue cycle, from prior auth to CDI to coding to claims management." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is AKASA?", Claude could identify the brand as of September 2026. AKASA is a healthcare technology company that builds AI-powered automation solutions for healthcare revenue cycle management, helping hospitals and health systems automate tasks like prior authorization, claims status checks, and coding. Best known for AI-driven automation for healthcare revenue cycle management (RCM).
When asked "Best brands similar to AKASA?", Claude would recommend AKASA as of September 2026. It's a recognized player in healthcare RCM automation, often mentioned alongside other health tech companies tackling administrative burden with AI.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
AKASA's main competitors in Healthcare: Waystar (86/100), R1 RCM (60/100), Olive AI (81/100), Notable Health (82/100), XSOLIS (76/100).
Sources: Brand Analyzer scan
AKASA has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 41, trust 29, recommendation 59). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: AKASA official site
AKASA was founded in 1995. AKASA operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
AKASA scores 59/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: AKASA official site
AKASA can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: AKASA official site
AKASA offers generative AI-powered solutions for healthcare revenue cycle management, including tools for prior authorization, clinical documentation improvement (CDI), medical coding, and claims management. These solutions are designed to help health systems and hospitals reduce claim denials and lower the cost-to-collect.
Sources: AKASA official site
AKASA is a healthcare technology company that develops generative AI (GenAI) solutions specifically designed for healthcare revenue cycle management. Its platform addresses tasks such as prior authorization, clinical documentation improvement (CDI), medical coding, and claims management for health systems and hospitals.
Sources: AKASA official site
AKASA builds generative AI tools that automate and optimize healthcare revenue cycle processes, including prior authorization, CDI, coding, and claims management. It combines revenue cycle management expertise with AI trained on clinical and financial data to help healthcare organizations reduce claim denials, lower cost-to-collect, and improve overall financial performance.
Sources: AKASA official site
AKASA's solutions are used by health systems, hospitals, and other healthcare organizations that are seeking to modernize and optimize their revenue cycle operations using artificial intelligence.
Sources: AKASA official site
AKASA scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
AKASA has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (59/100) and its weakest is trust (29/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,025,104 (Tranco) and a Moz Domain Authority of 42/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify AKASA from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to AKASA: AIA Singapore (82/100), American Hospital Dubai (82/100), ALASTIN Skincare (82/100), Ipsen (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.